Contaminated losartan sees 3.2m tablets recalled in Taiwan

By Ben Hargreaves contact

- Last updated on GMT

(Image: Getty/Ake Dynamic)
(Image: Getty/Ake Dynamic)

Related tags: Taiwan, losartan, valsartan

Taiwan’s Food and Drug Administration announced that Siu Guan will instigate a recall of 11 batches of blood pressure tablets.

Siu Guan Chemical Industries – operating out of Chiayi, Taiwan – has instigated a recall of 3.2m tablets of Cosar F.C. 50mg, which are used to control blood pressure.

The company initiated the recall after its own investigation discovered impurities within the medicine.

The losartan used as an active ingredient in the medicine was found to contain N-Nitrosodiethylamine (NDEA), classified as a probable carcinogen​.

According to a statement​ (link in Mandarin) released by the Taiwanese Food and Drug Administration, the company will recall the 11 batches over the course of January.

The agency also stated that it has strengthened its random testing procedure and has introduced requirements for the industry to conduct its own ‘self-inspections’.

Sin Guan was prompted to begin its tests after the discovery of contaminated valsartan products by the European Medicines Agency in July 2018​.

After the initial recall of valsartan produced by Chinese manufacturer, Zhejiang Huahai, the investigation spread further to impact a number of companies​. This led to the examinations of medicines produced using other ‘sartan’ medicines, such as losartan.

Related news

Show more

Related product

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

Related suppliers